Advertisement

Topics

"Resverlogix Announces Confirmation Regarding Filing Pathway Apabetalone" Drugs and Medication Database

17:36 EST 14th November 2018 | BioPortfolio

Here are the most relevant "Resverlogix Announces Confirmation Regarding Filing Pathway Apabetalone" Drugs and Medications that we have found in our database.

More Information about "Resverlogix Announces Confirmation Regarding Filing Pathway Apabetalone" on BioPortfolio

We have published hundreds of Resverlogix Announces Confirmation Regarding Filing Pathway Apabetalone news stories on BioPortfolio along with dozens of Resverlogix Announces Confirmation Regarding Filing Pathway Apabetalone Clinical Trials and PubMed Articles about Resverlogix Announces Confirmation Regarding Filing Pathway Apabetalone for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Resverlogix Announces Confirmation Regarding Filing Pathway Apabetalone Companies in our database. You can also find out about relevant Resverlogix Announces Confirmation Regarding Filing Pathway Apabetalone Drugs and Medications on this site too.

Showing "Resverlogix Announces Confirmation Regarding Filing Pathway Apabetalone" Drugs and Medications, all 8

Possibly Relevant

Hydrea [E.R. Squibb & Sons, L.L.C.]

HYDREA (hydroxyurea capsules, USP)

Droxia [E.R. Squibb & Sons, L.L.C.]

DROXIA (hydroxyurea capsules, USP)

Digoxin [DEPT HEALTH CENTRAL PHARMACY]

DIGOXIN - digoxin tablet West-ward Pharmaceutical Corp. ---------- DIGOXIN TABLETS, USP Revised 05/08 Rx Only

Hydroxyurea [American Health Packaging]

HYDROXYUREA CAPSULES, USPRx Only

Hydroxyurea [Par Pharmaceutical, Inc.]

Hydroxyurea [Physicians Total Care, Inc.]

Ciclopirox [Physicians Total Care, Inc.]

Gastromark [Mallinckrodt Inc.]

February 2010 300 mL 175 μg Fe/mL Gastromark™ [ferumoxsil, oral suspension] Mallinckrodt Inc. Rx only



Advertisement
Quick Search
Advertisement
Advertisement